How much revenue did MorphoSys generate this year?
MorphoSys has achieved a revenue of 251.6 M EUR this year.
MorphoSys Revenue 2024
MorphoSys Revenue
251.6 M EUR
MorphoSys Dividend yield
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys's sales reached 251.6 M EUR, a 5.59% difference from the 238.28 M EUR sales recorded in the previous year.
The MorphoSys Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2030e | - | - |
| 2029e | - | - |
| 2028e | - | - |
| 2027e | - | - |
| 2026e | - | - |
| 2025e | - | - |
| 2024e | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
| 2016 | - | - |
| 2015 | - | - |
| 2014 | - | - |
| 2013 | - | - |
| 2012 | - | - |
| 2011 | - | - |
| 2010 | - | - |
| 2009 | - | - |
| 2008 | - | - |
| 2007 | - | - |
| 2006 | - | - |
| 2005 | - | - |
| 2004 | - | - |
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding MorphoSys's Sales Figures
The sales figures of MorphoSys originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing MorphoSys’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize MorphoSys's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in MorphoSys’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about MorphoSys Stock
How much was the turnover of the company MorphoSys compared to the previous year?
The revenue of MorphoSys has increased by 5.59% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of MorphoSys?
The revenue of MorphoSys is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of MorphoSys measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of MorphoSys so important for investors?
The revenue of MorphoSys is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 4/30/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 4/30/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
